Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of sublingual tablets of
grass pollen allergen extract when initiated 2 months before the grass pollen season compared
with placebo for reduction of rhinoconjunctivitis symptoms and rescue medication usage.